keyboard_arrow_up

Industry Overview on Global Infertility Diagnosis and Treatment Market, 2015-2021

Global Infertility Diagnosis and Treatment Market Research and Analysis, 2015-2021 is a new market research publication announced by Reportstack. The Global infertility diagnosis and treatment market is expected to grow at CAGR of 6.3% from 2016 to 2021. In Vitro fertilization (IVF) is the largest segment of infertility diagnosis and treatment market and expected to be the largest segment in the year 2021 however Semen Analysis is the fastest growing segment of infertility diagnosis and treatment market with expected CAGR of XX% from 2016-2021. Lifestyle factors such as smoking, stress, weight and also the Female age factor (age above 35 years) are reason behind infertility.

The Global infertility diagnosis and treatment market is broadly categorized in two segments Male and female infertility. Male and female infertility market further divided in two major category Infertility Diagnosis and treatment market. North America (U.S.A. and Canada), Europe (Western Europe and rest of Europe), APAC (India, China and Japan) are major geographies which included in this report. North America is the largest market for the infertility diagnosis and treatment however APAC is the fastest growing market of infertility diagnosis and treatment with CAGR of xx% from 2016 to 2020.

Complete report available @ ​Global Infertility Diagnosis and Treatment Market Research and Analysis, 2015-2021.

Competitive landscape incudes market share analysis, Key company Analysis, Key strategies and corporate profiling. Companies profiled in the report are Bayer Ag, Bristol-Myers Squibb Co, Church & Dwight Company Inc., Cook Medical Inc., Coopersurgical Inc, Eli Lilly & Co., Emd Serono Inc, Endo Pharmaceuticals Inc, Ferring Pharmaceuticals, Genea, Glaxosmithkline Plc, Halotech Dna, Irvine Scientific, Janssen Pharmaceutical, Merck Serono, Novartis International Ag, Origio, Ovascience, Pfizer Inc, Princeton Biomeditech Corp, Progyny, Quidel Corp, Vitrolife Ab and Vivus Inc.


Companies Mentioned

1. BAYER AG 2. BRISTOL-MYERS SQUIBB CO. 3. CHURCH & DWIGHT COMPANY INC. 4. COOK MEDICAL, INC. 5. COOPERSURGICAL INC. 6. ELI LILLY & CO. 7. EMD SERONO, INC 8. ENDO PHARMACEUTICALS INC. 9. FERRING PHARMACEUTICALS 10. GENEA 11. GLAXOSMITHKLINE PLC 12. HALOTECH DNA 13. IRVINE SCIENTIFIC 14. JANSSEN PHARMACEUTICAL 15. MERCK SERONO 16. NOVARTIS INTERNATIONAL AG 17. ORIGIO 18. OVASCIENCE 19. PFIZER INC. 20. PRINCETON BIOMEDITECH CORP. 21. PROGYNY 22. QUIDEL CORP 23. VITROLIFE AB 24. VIVUS INC.


Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###